Surface modification of enzymes for therapeutic use: monomethoxypoly (ethylene glycol) derivatization of ribonuclease.
Bovine pancreatic ribonuclease A (RNase) was modified at various extent at the lysine residues by monomethoxypoly(ethylene glycol) (MPEG) activated as active ester. For pharmacokinetic experiments a radioactive adduct was also prepared with tritiated amino acid as spacer between polymer and protein. The modification reduced only slightly the RNase catalytic activity and Km towards the substrate cytidine-2',3'-cyclic monophosphate. On the other hand extensively modified MPEG-RNase samples, showed significant decrease in activity towards ribonucleic acid. The polymer modification did not change the pH activity profile, increased the stability to proteolytic digestion, while the behaviour towards denaturants and heat was not modified. The native and MPEG-RNase administered IV, IM and SC to rats, showed impressive differences in pharmacokinetics: the half-life of the modified enzyme, evaluated in blood by radioactivity, was increased of 40-50 folds with respect to the native form.
Schiavon
O
O
Dipartimento di Scienze Farmaceutiche, Università di Padova, Italy.
Caliceti
P
P
Sartore
L
L
Veronese
F M
FM
D000818:Animals; D002850:Chromatography, Gel; D003124:Colorimetry; D004355:Drug Stability; D004591:Electrophoresis, Polyacrylamide Gel; D006207:Half-Life; D007700:Kinetics; D008970:Molecular Weight; D011092:Polyethylene Glycols / Q000737:chemistry*; D011489:Protein Denaturation; D012313:RNA / Q000378:metabolism; D051381:Rats; D011919:Rats, Inbred Strains; D012259:Ribonuclease, Pancreatic / Q000737:chemistry* / Q000493:pharmacokinetics
D011092:Polyethylene Glycols; D012313:RNA; C028210:monomethoxypolyethylene glycol; D012259:Ribonuclease, Pancreatic